Zacks Investment Research downgraded shares of ICON PLC (ICLR) from OUTPERFORM to NEUTRAL on April 28, 2014, with a target price of $51.70.
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ICON PLC (ICLR),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment